Publications by authors named "Catherine Drai"

Claim this Profile
T
The European Medicines Agency's review of Kaftrio (elexacaftor-tezacaftor-ivacaftor): extending its use to all people with CF aged 2 years and older who do not have two class I variants.
Catherine Drai, Hanneke J van der Woude, Anne J Lexmond, Tineke van den Hoorn, Peter G M Mol

Eur Respir J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations.
Andreas Bonertz, Catherine Drai, Thomas Castelnovo, Diana Hartenstein, Susanne Kaul

Br J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory evaluation of Glybera in Europe - two committees, one mission.
Daniela Melchiorri, Luca Pani, Paolo Gasparini, Giulio Cossu, Janis Ancans, Catherine Drai

Nat Rev Drug Discov· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis